| 1 |
34687791 | Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma. | 2022 Jan 1 |
1 |
| 2 |
34072570 | PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells. | 2021 May 29 |
4 |
| 3 |
34664408 | YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. | 2021 Dec 7 |
1 |
| 4 |
31523192 | Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway. | 2019 |
6 |
| 5 |
29431743 | Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. | 2018 Mar |
3 |
| 6 |
29544563 | Sorafenib induces renal cell carcinoma apoptosis via upregulating activating transcription factor 4. | 2018 Mar 5 |
10 |
| 7 |
28553953 | ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. | 2017 Oct 5 |
2 |
| 8 |
29062139 | DDX3 regulates endoplasmic reticulum stress-induced ATF4 expression. | 2017 Oct 23 |
1 |
| 9 |
21601561 | Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression. | 2011 Aug 1 |
2 |